
Exxura 135mcg Solution for Injection
Marketer
Roche Products India Pvt Ltd
Salt Composition
Interferon Alpha 2A (135mcg)
Overview Exxura 135mcg Solution for Injection
Bendamustine 135mcg Injectable Solution treats follicular lymphoma and hairy cell leukemia by modulating cellular processes and immune responses. Administration is strictly via injection by a healthcare professional, with dosage and frequency determined by your physician based on your condition and subject to change. Adhere precisely to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include headache, influenza-like symptoms, diaphoresis, lassitude, and myalgia. Reduced white blood cell counts, increasing infection risk, are possible; regular blood tests monitoring blood cell counts, cardiac function, hepatic function, and glycemia are mandatory. Report any mood alterations, depression, or visual disturbances immediately. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all other medications, particularly those combating infections, as drug interactions are possible. This medication is contraindicated during pregnancy; effective contraception for both partners is essential throughout the treatment period.
Primary Ingredients of Exxura 135mcg Solution for Injection
No text provided to rephrase.
Uses of Exxura 135mcg Solution for Injection
Lymphoma of the follicle | Hairy-cell leukemia
Major Benefits of Exxura 135mcg Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
Common Side effects of Exxura 135mcg Solution for Injection:
- Decreased appetite
- Decreased calcium level in blood
- Decreased white blood cell count
- Diarrhea
- Fatigue
- Flu-like symptoms
- Hair loss
- Headache
- Joint pain
- Muscle pain
- Nausea
- Rigors
- Sweating
- Vomiting
How to use Exxura 135mcg Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
How Exxura 135mcg Solution for Injection works:
Injected Exxura 135mcg solution regulates the body's immunological response.
SAFETY ADVICE
AlcoholCAUTION
Use of Exxura 135mcg injectable solution with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Exxura 135mcg Injection Solution during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the inherent dangers. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Administration of Exxura 135mcg injectable solution during lactation is likely safe. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
Exxura 135mcg injectable solution's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Exxura 135mcg injectable solution cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The injectable formulation of Exxura (135 mcg) is likely safe for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, medical supervision is recommended. Routine monitoring of liver function is advised during treatment.
What if you forget to take Exxura 135mcg Solution for Injection :
Should you forget a dose of Exxura 135mcg injectable solution, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Exxura 135mcg Solution for Injection
| Label | Value |
|---|---|
| Chemical Type | Interferon proteins |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Interferon signaling |
